Leukemia, Prolymphocytic  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00452374: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

Completed
1/2
48
US
Cytarabine, Ara-C, Cytosar, DepoCyt, Cytosine arabinosine hydrochloride, Fludarabine, Fludara, Fludarabine Phosphate, Oxaliplatin, Eloxatin, Rituximab, Rituxan
M.D. Anderson Cancer Center, Sanofi
Leukemia
01/11
01/11
NCT00472849: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

Checkmark aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome
Jul 2013 - Jul 2013: aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome
Checkmark P1/2 data release
Jun 2011 - Jun 2011: P1/2 data release
Completed
1/2
92
US
Oxaliplatin, Fludarabine, Fludara, Cytarabine, Cytosar, Ara-C, Rituximab, Rituxan, Pegfilgrastim, Neulasta
M.D. Anderson Cancer Center, Sanofi
Richter's Transformation, Leukemia
02/12
02/12

Download Options